skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radionuclide evaluation of free vascularized bone graft viability. [/sup 99m/Tc-methylene diphosphonate]

Abstract

Free vascularized bone grafting is a new technique applied to the reconstructive surgery of long bones affected by aggressive benign or malignant processes, as well as traumatic deficiencies. These bone lesions may be treated by en bloc excision and replacement with fibular segments or osteocutaneous flaps from the groin isolated on their vascular pedicle. Microvascular anastomosis of the pedicle at the recipient site is necessary. Radionuclide bone imaging is unique in the assessment of the free vascularized bone graft because postoperative graft uptake of radiopharmaceutical reflects patent anastomoses and segmental bone viability.

Authors:
; ;
Publication Date:
Research Org.:
McGill Univ., Montreal, Canada
OSTI Identifier:
5264869
Resource Type:
Journal Article
Resource Relation:
Journal Name: Am. J. Roentgenol.; (United States); Journal Volume: 134:2
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; 63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.; BONE TISSUES; RADIONUCLIDE KINETICS; GRAFTS; SKELETON; SCINTISCANNING; TECHNETIUM 99; BLOOD VESSELS; DIAGNOSIS; ISOMERIC NUCLEI; PATIENTS; PHOSPHONIC ACID ESTERS; RADIOPHARMACEUTICALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; DRUGS; ESTERS; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANIC PHOSPHORUS COMPOUNDS; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPE SCANNING; RADIOISOTOPES; TECHNETIUM ISOTOPES; TISSUES; TRANSPLANTS; YEARS LIVING RADIOISOTOPES; 550601* - Medicine- Unsealed Radionuclides in Diagnostics; 560171 - Radiation Effects- Nuclide Kinetics & Toxicology- Man- (-1987)

Citation Formats

Lisbona, R., Rennie, W.R.J., and Daniel, R.K.. Radionuclide evaluation of free vascularized bone graft viability. [/sup 99m/Tc-methylene diphosphonate]. United States: N. p., 1980. Web. doi:10.2214/ajr.134.2.387.
Lisbona, R., Rennie, W.R.J., & Daniel, R.K.. Radionuclide evaluation of free vascularized bone graft viability. [/sup 99m/Tc-methylene diphosphonate]. United States. doi:10.2214/ajr.134.2.387.
Lisbona, R., Rennie, W.R.J., and Daniel, R.K.. Fri . "Radionuclide evaluation of free vascularized bone graft viability. [/sup 99m/Tc-methylene diphosphonate]". United States. doi:10.2214/ajr.134.2.387.
@article{osti_5264869,
title = {Radionuclide evaluation of free vascularized bone graft viability. [/sup 99m/Tc-methylene diphosphonate]},
author = {Lisbona, R. and Rennie, W.R.J. and Daniel, R.K.},
abstractNote = {Free vascularized bone grafting is a new technique applied to the reconstructive surgery of long bones affected by aggressive benign or malignant processes, as well as traumatic deficiencies. These bone lesions may be treated by en bloc excision and replacement with fibular segments or osteocutaneous flaps from the groin isolated on their vascular pedicle. Microvascular anastomosis of the pedicle at the recipient site is necessary. Radionuclide bone imaging is unique in the assessment of the free vascularized bone graft because postoperative graft uptake of radiopharmaceutical reflects patent anastomoses and segmental bone viability.},
doi = {10.2214/ajr.134.2.387},
journal = {Am. J. Roentgenol.; (United States)},
number = ,
volume = 134:2,
place = {United States},
year = {Fri Feb 01 00:00:00 EST 1980},
month = {Fri Feb 01 00:00:00 EST 1980}
}